Dr Kent Holtorf delivers his presentation on Thyroid Conditions at the LDN 2014 Conference.

In this presentation Dr Holtorf speaks about the mechanisms which Hashimoto’s and Grave’s disease operate under and how, after many years of research and practice, they can be countered through unconventional treatments.

Kent Holtorf, MD - Thyroid Disorders (2016 Conference) (LDN, low dose naltrexone)

Download Dr. Holtorf's Thyroid Presentation

Jill Cottel, MD - Treating the Zebras in Primary Care (2017 Conference) (LDN, low dose naltrexone)

In this presentation Dr Cottel shares case studies of patients:

36 year old woman with Ehlers-Danlos Syndrome. This lady was started on Low Dose Naltrexone (LDN) at 1.5mg, increased to 3 mg and found she lost her earlier improvement but on going down to a much lower dose she improved significantly. 

Laurie Marzell, ND - LDN Case Studies (2017 Conference) (LDN, low dose naltrexone)

Finding your optimal dose of LDN for Hashimoto's (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Ani talks about LDN for Hashimoto's - 5th August 2020 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Ani shares her Hashimoto's and Low Dose Naltrexone (LDN) story on the LDN Radio Show with Linda Elsegood.

Paul Anderson, NMD - Case Studies (2017 Conference) (LDN, low dose naltrexone)

The first case is an oncology patient, a 47 year old female with colorectal cancer.  This lady presented herself while halfway through standard cancer treatment.  Dr Anderson added many adjunct therapies as well as Low Dose Naltrexone and the patients tumour markers reduced for the first time.

Harpal Bains, MBBS - Managing Hashimotos: Are We Asking the Right Questions in Hypothyroidism? (2018 Conference) (LDN, low dose naltrexone)

Viv-Hashimoto’s Thyroiditis-Scotland (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Deb - Hashimoto’s, Celiac Disease Pernicious Anemia, Vitiligo - US (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.